CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Gynecologic Cancers

ONCOLOGY. Vol. 21 No. 5
Pages: 1  2  3  4  
Previous Next
REVIEW ARTICLE 

Reproductive Issues in the Gynecologic Cancer Patient

By Jeanne Carter, PhD1, Sharyn Lewin, MD2, Nadeem Abu-Rustum, MD3, Yukio Sonoda, MD4 | April 30, 2007
1Assistant Attending Psychologist, Department of Psychiatry and Behavioral Sciences, Department of Surgery, Gynecology Service 2Fellow, Department of Surgery, Gynecology Service 3Director, Minimally Invasive Surgery, Department of Surgery, Gynecology Service 4Assistant Attending Surgeon, Department of Surgery, Gynecology Service, Memorial Sloan-Kettering Cancer Center, New York, New York

As medical technology advances, women diagnosed with and treated for cancer not only have an improved likelihood of survival, but also the availability of emerging assisted reproductive techniques. Schover and colleagues assessed the attitudes of individuals with a history of cancer and found that younger cancer survivors view parenthood as a positive experience. Participants also expressed the belief that their experience with cancer would make them better parents, and 60% indicated that being a parent would be an important life goal even if they died young.[16] Traditionally, women with gynecologic cancer are coping with treatment options that consist of total or partial removal of the reproductive organs. In some cases, individuals may be eligible for conservative fertility-preserving treatment, as described above, enabling reproductive capacity in survivorship.

•Third-Party Parenting—For many cancer survivors, however, family-building options will require the assistance of another individual or third-party reproduction. Third-party parenting is the involvement of a third person, beyond the parenting couple or single parent, in order to create a baby. Techniques can include egg (oocyte) donation, sperm donation, embryo donation, in vitro fertilization (IVF) with or without a gestational carrier (surrogacy), and/or adoption. When possible, preservation of the ovaries offers the possibility of a biological child through assisted reproduction with egg retrieval.

(MORE: Gynecologic Cancer Survivors: A Comprehensive Approach)

•Third-Party Parenting—For many cancer survivors, however, family-building options will require the assistance of another individual or third-party reproduction. Third-party parenting is the involvement of a third person, beyond the parenting couple or single parent, in order to create a baby. Techniques can include egg (oocyte) donation, sperm donation, embryo donation, in vitro fertilization (IVF) with or without a gestational carrier (surrogacy), and/or adoption. When possible, preservation of the ovaries offers the possibility of a biological child through assisted reproduction with egg retrieval.

Gynecologic cancer survivors who undergo a hysterectomy as part of their treatment may not consider themselves as having fertility options, such as pursuing ovarian stimulation for oocyte retrieval and IVF with surrogacy. These techniques can offer hope to many cancer survivors, but awareness and access are necessary. For women who require the removal of their ovaries or are at high risk for treatment-induced acute ovarian failure,[60,61] oocyte donation can be a family-building option, allowing for pregnancy and childbirth. If treatment requires the removal of the uterus, a surrogate or gestational carrier would be necessary.

Even in the case of a woman needing a hysterectomy and oophorectomy as part of cancer treatment, advances in reproductive technology have given these women multiple options and alternatives to create a family, such as embryo donation, oocyte donation with a partner's sperm (or donor sperm) with IVF, and surrogacy. The practice of gestational surrogacy can be a controversial procedure in the field of assisted reproduction, with legal issues varying by state. Nonetheless, it is a successful treatment option for women who would otherwise be unable to have a child.[62] That said, cancer survivors with impaired fertility may not view themselves as appropriate candidates for reproductive services or as having family-building options, such as third-party parenting.

•Emotional Issues—Treatments for infertility can create a host of emotional issues as well as tax women and couples physically and financially.[63] Female survivors may also struggle with concerns about the health risks of pregnancy and risks to genetic offspring.[15] While adoption exists as an alternative, this option may entail a difficult and emotionally painful process for survivors who confront the loss of their own reproductive ability as well as the possibility of a hostile legal environment that may question the role of a cancer survivor as a parent. A recent study found that adoption agencies may be reluctant to consider cancer survivors as potential parents.[64] Growing concern over the late health risks after cancer treatment may also present barriers to the adoption process.[15,64]

•Economic Issues—The prohibitive expense of assisted reproduction generally limits its availability to those of higher socioeconomic status. Thus, reproductive assistance is far more prevalent among married, older, more educated, and more affluent women than in the general population of women with impaired fertility.[65,66] Moreover, most infertility services are not covered by insurance policies. Additional obstacles to accessing reproductive services may include low literacy or educational limitations, language barriers, and a lack of culturally sensitive information, all of which are more prevalent among patients of lower socioeconomic status.[67]

Many young cancer survivors experience financial constraints as a result of their cancer treatment. To compound such preexisting financial burdens with the added cost of assisted reproductive services may deter many from seeking treatment. Research suggests that having insurance coverage is significantly associated with the utilization of infertility services.[67,68] The lack of insurance coverage for infertility treatments raises several ethical considerations, particularly in the context of cancer care and impaired fertility secondary to treatment.[16]

Cancer-Related Infertility

Research has shown that infertility as a singular health concern can have distress levels comparable to those of coping with a life-threatening illness such as cancer.[69] The turmoil experienced by women simultaneously facing a cancer diagnosis and the possibility of infertility has been proposed to be a compounding event,[15,70] described as "adding insult to injury"[18] or a double trauma.[17,71] The synergistic effect of coping with two traumas increases vulnerability to psychological distress. Baider et al[17] described the phenomenon of double trauma while studying second-generation Holocaust survivors with a cancer diagnosis. Therefore, one could propose that the experience of both cancer and infertility would be a risk factor for prolonged grief reactions and poor coping. Survivors must confront both a perceived and real physical threat of infertility as they attempt to form families in the posttreatment period.

The emotional, psychosexual morbidity and quality-of-life impact of cancer-related infertility is not well documented. However, clinical observations have documented that these women experience severe psychological distress.[15] A number of factors may be responsible for the high level of emotional turmoil related to infertility associated with cancer. Women are forced to make treatment choices for survival that have a negative impact on fertility and decisions of childbearing. Although infertility is a common consequence of some cancer treatments, it is usually a secondary concern in relation to survival in the initial phases of treatment.[18] For some women, infertility may be unexpected because they were unable to process or retain information about the side effects of treatment outlined by the oncologist during the discussion of treatment.[15] Corney and colleagues[72] found that women experiencing infertility following treatment for gynecologic malignancies felt deprived of choice, and that medical professionals tended to minimize the sense of loss experienced by older women.[72]

A recent study in a small sample of gynecologic cancer survivors found that women with infertility as a result of their cancer treatment experienced persistent feelings of sadness and grief lasting more than 1 year posttreatment.[70] The psychological experience, however, varies from woman to woman, depending on the cause, the degree of fertility impairment, the importance placed on having a biological child, and the availability of reproductive assistance or willingness to adopt.

Fertility options are a critical consideration in the context of both having a first child and expanding family size. While there are more reproductive options today, such as egg retrieval with a surrogate, egg donation, and adoption, the sense of not having one's own biological child can be very traumatic. Additionally, the available assistive reproductive treatments are strenuous on a woman's physical, emotional, and financial resources. Our clinical experience with these women has revealed that many grieve their lost fertility. These grieving symptoms can contribute to greater distress[70] and negatively impact quality of life in survivorship.[14]

It is not uncommon for infertility to be coupled with sexual dysfunction and menopause secondary to cancer treatment.[70,73] These problems are often not discussed due to the stigma of gynecologic cancer, the sense of being "different" or "damaged goods," and the anger of being subjected to such an unfortunate fate. Many women experience social isolation concurrent with psychological, psychosocial, and at times psychiatric disorders, such as anxiety and depression—significant problems that would benefit from recognition and treatment.[18] Ideally, these issues should be identified during treatment with the hopes that early intervention might be able to prevent more serious long-term sequelae.

Pages: 1  2  3  4  
Previous Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

This article reviewed

Fertility Preservation in the Gynecologic Cancer Patient

Gynecologic Cancer Survivors: A Comprehensive Approach






 
RELATED CONTENT

The Key to Improving Survival in Ovarian Cancer: Better Screening of Women With Vague Symptoms, Leading to Earlier Diagnosis, More Effective Surgery
ONCOLOGY,  June 18, 2013
HE4—Another Marker for Gynecologic Cancers: Do We Really Need One?
ONCOLOGY,  June 18, 2013
HE4: Another ‘Player’ in the Epithelial Tumor Marker Arena?
ONCOLOGY,  June 18, 2013
The Emerging Role of HE4 in the Evaluation of Epithelial Ovarian and Endometrial Carcinomas
ONCOLOGY,  June 18, 2013
A 48-Year-Old Woman With Irregular Vaginal Bleeding
June 10, 2013
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
  • ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
  • Physical Activity Across the Cancer Continuum
  • Exercise After Cancer Diagnosis: Time to Get Moving
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • ASCO: No Benefit From Avastin in Newly Diagnosed Glioblastoma
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Gynecologic Cancer
Evidence on Gynecologic Cancer
Guidelines on Gynecologic Cancer
Patient Education on Gynecologic Cancer
Clinical Trials on Gynecologic Cancer
Practical Articles on Gynecologic Cancer
Research and Reviews on Gynecologic Cancer
All "Gynecologic Cancer" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy